MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.76 -0.12 (-6.82%) 0.0 (0.0%) 0.01 (0.61%) -0.12 (-6.82%) --- --- -0.12 (-6.82%) -0.12 (-6.82%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-18.2222
Diluted P/E:
-18.2222
RSI(14) 1m:
57.16
VWAP:
1.65
RVol:
0.0934

Events

Period Kind Movement Occurred At
1m Price increase 1m 2.58 +0.07 (+2.79%) Oct 16 06:51
1m Price increase 1m 2.51 +0.03 (+1.21%) Oct 16 06:50
1m Price increase 1m 2.49 +0.04 (+1.63%) Oct 16 06:49
1m Price decrease 1m 2.45 -0.08 (-3.16%) Oct 16 06:48
1m Price decrease 1m 2.53 -0.1 (-3.8%) Oct 16 06:47

Related News